You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 8, Issue 2

June 2015 - 14 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Article
  • Open Access
6 Citations
6,079 Views
14 Pages

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism

  • Heinz Zoller,
  • Annina Jenal,
  • Albert F. Staettermayer,
  • Sebastian Schroecksnadel,
  • Peter Ferenci and
  • Dietmar Fuchs

18 June 2015

Until recently, the standard treatment of chronic hepatitis C virus (HCV) infection was a combination therapy with PEG-IFN-α plus ribavirin. Previous studies have proven that several markers predict the outcome of such therapy, e.g., pretreatment pla...

  • Article
  • Open Access
28 Citations
8,625 Views
15 Pages

18 June 2015

We investigated the effect of a formula containing two different prebiotics (bifidogenic growth stimulator and galacto-oligosaccharide) and fermented milk products on intestinal microbiota and antibody responses to an influenza vaccine in enterally f...

  • Review
  • Open Access
209 Citations
14,526 Views
16 Pages

A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?

  • Robin M. De Kruijff,
  • Hubert T. Wolterbeek and
  • Antonia G. Denkova

10 June 2015

This review presents an overview of the successes and challenges currently faced in alpha radionuclide therapy. Alpha particles have an advantage in killing tumour cells as compared to beta or gamma radiation due to their short penetration depth and...

  • Review
  • Open Access
49 Citations
10,936 Views
18 Pages

9 June 2015

X-linked dilated cardiomyopathy (XLDCM) is a distinct phenotype of dystrophinopathy characterized by preferential cardiac involvement without any overt skeletal myopathy. XLDCM is caused by mutations of the Duchenne muscular dystrophy (DMD) gene and...

  • Article
  • Open Access
37 Citations
7,851 Views
24 Pages

Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2

  • Faten Alchab,
  • Laurent Ettouati,
  • Zouhair Bouaziz,
  • Andre Bollacke,
  • Jean-Guy Delcros,
  • Christoph G.W. Gertzen,
  • Holger Gohlke,
  • Noël Pinaud,
  • Mathieu Marchivie and
  • Jean Guillon
  • + 3 authors

8 June 2015

Due to their system of annulated 6-5-5-6-membered rings, indenoindoles have sparked great interest for the design of ATP-competitive inhibitors of human CK2. In the present study, we prepared twenty-one indeno[1,2-b]indole derivatives, all of which w...

  • Article
  • Open Access
11 Citations
7,888 Views
20 Pages

Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells

  • Mark C. Bagley,
  • Mohammed Baashen,
  • Irina Chuckowree,
  • Jessica E. Dwyer,
  • David Kipling and
  • Terence Davis

3 June 2015

Microwave-assisted Suzuki-Miyaura cross-coupling reactions have been employed towards the synthesis of three different MAPKAPK2 (MK2) inhibitors to study accelerated aging in Werner syndrome (WS) cells, including the cross-coupling of a 2-chloroquino...

  • Review
  • Open Access
15 Citations
6,934 Views
7 Pages

Immunotherapeutic Applications of NK Cells

  • Carter T. Davis and
  • David Rizzieri

25 May 2015

Natural Killer (NK) cells are lymphoid cells that exhibit an innate response against virus-infected cells. These cells are also capable of mounting an immune response against tumor cells after education through major histocompatibility complex (MHC)...

  • Article
  • Open Access
9 Citations
5,119 Views
9 Pages

8 May 2015

Seven novel N-arylsulfonyl-3-(2-yl-ethanone)-6-methylindole derivatives 4a–f and 6 were readily synthesized and have been identified as inhibitors of human immunodeficiency virus type-1 (HIV-1) replication. Initial biological studies indicated that a...

  • Review
  • Open Access
40 Citations
10,359 Views
20 Pages

Seatbelts in CAR therapy: How Safe Are CARS?

  • Kentaro Minagawa,
  • Xiaoou Zhou,
  • Shin Mineishi and
  • Antonio Di Stasi

8 May 2015

T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247